CDKN1A and cancer: We show here that spike can alter p53 transcriptional activity in wild-type p53-expressing cancer cells based on reduction of the p53-responsive reporter activity and a decrease in selected p53 targets such as p21(WAF1) or TRAIL Death Receptor DR5 at the protein level.